IE
AVXL icon

Israel Englander’s Anavex Life Sciences AVXL Stock Holding History

Israel Englander’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$1.73M – 6890
2021
Q4 		$1.73M Buy
+100,000
New +$1.9M ﹤0.01% 3906

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Israel Englander's AVXL Position: Q2 2026 in Review

Israel Englander opened a new position in Anavex Life Sciences (AVXL) in Q2 2026: 60,483 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #5383 among its holdings. This is a return to the name: Israel Englander previously reported a position in AVXL as recently as Q1 2025.

Israel Englander first reported a position in AVXL in Q4 2015 and has held it in 31 quarters since. The position peaked at $7.72M in Q4 2022. 178 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Israel Englander held 60,483 shares of Anavex Life Sciences worth $157K as of Q2 2026.
  • Anavex Life Sciences was a new Israel Englander position in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5383 holding.
  • Israel Englander first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 31 quarters since.
  • Israel Englander's Anavex Life Sciences position peaked at $7.72M in Q4 2022.
  • 178 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.